European Pharmaceutical Review

JANUARY 30, 2024

Ryzneuta (efbemalenograstim alfa) received a positive opinion from the CHMP as a medicine to reduce the duration of neutropenia and the incidence of febrile neutropenia due to chemotherapy. Additionally, a positive opinion for Niapelf (paliperidone), a generic medicine for schizophrenia was adopted in the meeting.

Generic Medicine 98

Generic Medicine Chemotherapy Hospitals 98

European Pharmaceutical Review

APRIL 30, 2024

If approved, fruquintinib could provide a new oral, chemotherapy-free option as the first and only selective inhibitor of all three vascular endothelial growth factor receptors (VEGFR) receptors approved in the EU for this disease, according to Takeda. This covers paediatric plaque psoriasis, psoriatic arthritis and Crohn’s disease.

Generic Medicine 98

Generic Medicine Chemotherapy Hospitals FDA 98

European Pharmaceutical Review

APRIL 3, 2023

The committee recommended granting a paediatric-use marketing authorisation (PUMA) for Pedmarqsi (sodium thiosulfate) for preventing ototoxicity induced by cisplatin chemotherapy. Ototoxicity is the development of hearing or balance problems due to a medicine. Cisplatin is a chemotherapy used to treat several types of cancer.

Vaccines 98

Vaccines Chemotherapy Generic Medicine 98

pharmaphorum

OCTOBER 6, 2022

The latter brought in acute myeloid leukaemia (AML) and cholangiocarcinoma therapy Tibsovo (ivosidenib), which was approved as a first-line therapy for AML last year in combination with Bristol-Myers Squibb’s chemotherapy Vidaza (azacitidine), dramatically expanding the eligible patient population for the drug.

Generic Medicine 96

Generic Medicine Chemotherapy 96

BuzzRx

FEBRUARY 6, 2023

However, triggers outside the digestive system can also result in nausea or vomiting, such as pregnancy-associated nausea (morning sickness), chemotherapy-associated nausea, and nausea caused by motion sickness, inner ear problems, migraine headaches, head injuries, brain infections, or tumors. Cannabinoids Examples: Nabilone.

Chemotherapy 52

Chemotherapy Generic Medicine Immunization 52

European Pharmaceutical Review

DECEMBER 19, 2022

The group adopted a positive opinion for Tremelimumab AstraZeneca (tremelimumab), to treat metastatic non-small cell lung cancer (NSCLC) in combination with Imfinzi (durvalumab) and platinum-based chemotherapy. This rare genetic disorder causes muscle weakness and is often fatal.

Generic Medicine 104

Generic Medicine Vaccines Chemotherapy 104